From mboxrd@z Thu Jan 1 00:00:00 1970 Return-Path: Received: from NAM11-BN8-obe.outbound.protection.outlook.com (mail-bn8nam11on2100.outbound.protection.outlook.com [40.107.236.100]) by sourceware.org (Postfix) with ESMTPS id 5B0973858D20 for ; Tue, 27 Feb 2024 05:16:54 +0000 (GMT) DMARC-Filter: OpenDMARC Filter v1.4.2 sourceware.org 5B0973858D20 Authentication-Results: sourceware.org; dmarc=pass (p=quarantine dis=none) header.from=ufpr.br Authentication-Results: sourceware.org; spf=pass smtp.mailfrom=ufpr.br ARC-Filter: OpenARC Filter v1.0.0 sourceware.org 5B0973858D20 Authentication-Results: server2.sourceware.org; arc=pass smtp.remote-ip=40.107.236.100 ARC-Seal: i=2; a=rsa-sha256; d=sourceware.org; s=key; t=1709011016; cv=pass; b=mFsuwPm5037rG/ME8MH2aorDj4S48OO1Sz5DC81vz67gJthfvDFIYy8GHUnwDuqI5VJV8m1AavGuhNHcBJdhOJ1ZLf9CjcS0SEVZghFgZGTiSh0dYyzcMg3Iu4IYnku65piLyFOwTXyfOHc5416sxoV4BT8rFjt5FnZ0DnqlI54= ARC-Message-Signature: i=2; a=rsa-sha256; d=sourceware.org; s=key; t=1709011016; c=relaxed/simple; bh=rHZgBHbqfDBNORmHigooWCNGkHZZpXllrXNHrPfkBMM=; h=DKIM-Signature:From:Subject:Date:Message-ID:MIME-Version; b=c7TI/AufGoXmM6VzZyKVUGyqlhuUZsXMJDTLXYGK/mcTXhH3n/99xF32Q+yBjOJEo4XfhmUdx1OHPaqFAu2iyK5Gs5QnfXkJYbYTBX6R0W//QBt3pE8TcOzdCR4WwFqXMTx8vSsknxBnvT7oe5yqNzB3MSZK71k7n5LpGJyo3VQ= ARC-Authentication-Results: i=2; server2.sourceware.org ARC-Seal: i=1; a=rsa-sha256; s=arcselector9901; d=microsoft.com; cv=none; b=UWwvUJPdUy4dYmjk3JME84oys5lpKJrKqfVo19JDYxHWutpk2l2Kwb1qqR5FLEmKOyryHU6e4E378LvtKWD5SdBEEv7Ae1RRoa4/9B0Fk4z40DPNxlHoBfV+6JdorBU28S7+K5ZOhg5n+I+PzFdO4jgLG0aerkDFZlCj1a+pDcxc7FKUikWnNcHvyP8QiscoMBGjNjuwb7t1j7r98GwWSSfECT1zFIdaixiy42fKL5DdDH4mJwIWUcJySKgC7a0fc+F3oQUtNGcPt9uOPpNe6w7diun7Ro9f+HaKGtvLHj1gdSkxjt+tg4FUXupItmE7txZMFrp0rxAxl2hX6kvKfA== ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=microsoft.com; s=arcselector9901; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-AntiSpam-MessageData-ChunkCount:X-MS-Exchange-AntiSpam-MessageData-0:X-MS-Exchange-AntiSpam-MessageData-1; bh=rHZgBHbqfDBNORmHigooWCNGkHZZpXllrXNHrPfkBMM=; b=drnNEJTmK5L6bFxeH2YT477yzsv/4R6xocskWCGtt+okO8np1kdkF6WEuCI5VXM1vPGyGj01TcIkY6eyamZgWYTvUIkwSMqDOSyurEQmVIQKQxh0fhxffGnSgp4GpcF3c/aATmz65WYCS341aYnZzO15vbMRRWchY4t40CMNavINQxMEe/69ooWE2vtrsi0x3o5blEqr2CSRvox43ROUVX7ARUM00bsOFICt0nbDlh+Oy5oKncLT2Y72nYle8dvTX46wCZBCqFCs+VVjnU+NHd8eUBGAVnsucxpULkk6b2tZpmow8OCqdR7gWa+4qloDrMBaWsb1NpEO2SRkLmipFQ== ARC-Authentication-Results: i=1; mx.microsoft.com 1; spf=pass smtp.mailfrom=ufpr.br; dmarc=pass action=none header.from=ufpr.br; dkim=pass header.d=ufpr.br; arc=none DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=ufpr.br; s=selector1; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-SenderADCheck; bh=rHZgBHbqfDBNORmHigooWCNGkHZZpXllrXNHrPfkBMM=; b=pwBxctw/8kxshSZrOPrp0sbMeRktibSKZ/3gHsKz2n/mAzkao2NjRjimi011YYHNyolfOpIUNRfeaMHHBXPEGRACD6UFQ1iJfAxAi10S9sIR0w3q1C+GVZBoy32TZq+VUiF4JiuVkdSEZEIt5w7RYequcylzGXGZz3MbUHp7uqE= Received: from SCZP152MB5822.LAMP152.PROD.OUTLOOK.COM (2603:10d6:300:60::7) by CPTP152MB4197.LAMP152.PROD.OUTLOOK.COM (2603:10d6:103:103::6) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.7316.34; Tue, 27 Feb 2024 05:16:51 +0000 Received: from SCZP152MB5822.LAMP152.PROD.OUTLOOK.COM ([fe80::59e3:ab89:f4ae:568c]) by SCZP152MB5822.LAMP152.PROD.OUTLOOK.COM ([fe80::59e3:ab89:f4ae:568c%7]) with mapi id 15.20.7316.037; Tue, 27 Feb 2024 05:16:51 +0000 From: Ana Clara Corradi Jorge Subject: Supplier Needed Thread-Topic: Supplier Needed Thread-Index: AQHaaPg9IgLIdV3CFEmQ7Vp7xbrZbrEdJUhOgAAAQneAAAAqgYAAAD6KgAAAJJOAAAKD2YAAADIbgAAATAyAAABBEoAAAEncgAAAJDSAAAAkmoAAAFCfgAAAHvuAAAAncYAAAGLDgAAAbsmAAANeWIAAADp2gAAAMtmAAAAzS4AAACU6gAAAyyKAAABbeoAAADkUgAAALlWAAACvCYAAACnjgAAAOYSAAAAnGIAAALaggAAAMVCAAAA5hYAAADAugAAALC6AAAA3WoAAAEHzgAAANpiAAGftKYAAADN3gAAAH5KAAAA3dYAAAD4/gAAAL7WAAABTjoAAACk+gAAANz6AAABIYoAAACpRgAAARL6AAABKPYAAAEFsgAAAK4iAAAA2eIAAADQ4gAAAY9iAAAA62YAAAGVggAAAKAWAAABXjYAAAD3ygAAB/02AAAEiBoAAAFsFgAAAPPKAAACA/4AAAEEVgAAATbQ= Date: Tue, 27 Feb 2024 05:16:51 +0000 Message-ID: References: In-Reply-To: Accept-Language: pt-BR, en-US Content-Language: pt-BR X-MS-Has-Attach: X-MS-TNEF-Correlator: msip_labels: authentication-results: dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=ufpr.br; x-ms-publictraffictype: Email x-ms-traffictypediagnostic: SCZP152MB5822:EE_|CPTP152MB4197:EE_ x-ms-office365-filtering-correlation-id: f7be7eae-f9b5-4731-77d9-08dc37534e74 x-ms-exchange-senderadcheck: 1 x-ms-exchange-antispam-relay: 0 x-microsoft-antispam: BCL:0; x-microsoft-antispam-message-info: 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 x-forefront-antispam-report: CIP:255.255.255.255;CTRY:;LANG:en;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:SCZP152MB5822.LAMP152.PROD.OUTLOOK.COM;PTR:;CAT:NONE;SFS:(13230031)(38070700009);DIR:OUT;SFP:1102; x-ms-exchange-antispam-messagedata-chunkcount: 1 x-ms-exchange-antispam-messagedata-0: =?iso-8859-1?Q?c75uxGtLXxqpfHIn7TwP2PBBVVTqo0h7C8hLv7ReJgFfCNN7EqIUK8KDR0?= =?iso-8859-1?Q?dJaDPiE/W8EpF+w5w6G8ZKOiy7M+SbcTALWBWmyZbiWIKzApR8sOWCnjjr?= =?iso-8859-1?Q?VAPOBZECq/U00SqCQxXwTcCEOgb0yEVu/QmSJ1Z8UOTeVnBPl5NHnVaoBn?= =?iso-8859-1?Q?AcEWOPnlae3MXF5caFLu6Nw63NmneM44n9VvtJaWgB7qKPjbNPJgWWs+qI?= =?iso-8859-1?Q?7yeIT3qOxOeumttMUhxUc5vDPGFvBOxQLUW38gvHdisReZ6BtpcZScNpMO?= =?iso-8859-1?Q?CYSqi6OhP3ChQKa5QiIQGtgeTiwFrDa4erOQ5ga4jet4sZ/6g9MgPYRmea?= =?iso-8859-1?Q?vP2jyh3uLSoAgmI4ZWnw2tEmCMnfJWTzjTgthduYsxXDIe4jhqScCWKskX?= =?iso-8859-1?Q?AJHtgdknTnVFI2eAx6ng/YgFgxBvtlqEXRADsoAJbvVNBIJeWd1yesba0e?= =?iso-8859-1?Q?OjoTKzivOP5zT7+pB/hB1scxv/z9gtFC4QJ1T4zRPk9cI+pfyG3rHN6u5m?= =?iso-8859-1?Q?I2YCPg0RrLCtTJGfhpvfOnAlR8Ck24sy5et1yKuNfoafz/7PpDWYBdbK7q?= =?iso-8859-1?Q?u6oodDgRgROgRKc3EVNlH2FeZ8NjPypzbHdEYCG+A/+GGUGOzDfe8/+7Uz?= =?iso-8859-1?Q?Q35G6tT3jeUcJ/12mlUYuA+gWliRSvXb0fNq8uW01ueUH9iOIbSPKRb8IS?= =?iso-8859-1?Q?vCRjFeD14A/5hZGIrSLIc83o3VbYadvEzqyz05R3iRHnqyw/tfyosknnUJ?= =?iso-8859-1?Q?/9E9W75Mipvkn2IRSWq8jKn3JPTbv9aI8TkuIjwC8S9S2Khh5Q8t69vhn7?= =?iso-8859-1?Q?T96v0TYLFK1/c1ZpJDejmxF+/cvaifl590xBHFqCWD/ZMZyfI9ZTD6+e7J?= =?iso-8859-1?Q?PSmhw5ZsfAGWOs/hbsfQmqMT9e0yAg4ykecS8XyFcPDjS5MLjsdBOBPzW3?= =?iso-8859-1?Q?srq70C7GScXAlbuiuAF3QenZVRkI30Pq7P3QUWWOo3UK3lDJKetHBnYWCn?= =?iso-8859-1?Q?ONnfUeA1KxLjpBlUtOwL7A0bYpqGezT8eJib8kgMvRnZz+/KFp+EJcZ19e?= =?iso-8859-1?Q?wO+ZqRCzVSezFqwfIDazOf5JBnXEgfx1srQou3Uhv8atA827r17a4kitgQ?= =?iso-8859-1?Q?65QdqI2TEgIXKcIXCQhk2yDBVWtMEIg/4GZW1N1CJYE9oRVN+gE6hGA4tX?= =?iso-8859-1?Q?Euxri1MAEkMTe1K6/QAZbFF9pSv7tftTjf9Kdodel3WDZy9JUTDntzDn/v?= =?iso-8859-1?Q?N9JIGG5v5giVgqAo5imaBvrKQW31HL8b+gZa59/HqGEHRASlC+kYiBaZeI?= =?iso-8859-1?Q?Lz4ik3clJyqWeuoqX3fyXWvuxjbZxhR6SLF3hv4Xsau2uApxplr375Xc0b?= =?iso-8859-1?Q?22xxeThPdO3/+PGgmwyB43mgDtRcZvSkaoEU4qhL2AD7GRofHchtA5/MsI?= =?iso-8859-1?Q?aJPIz05OV2m6x15Ry3K9ZevAuv7lwA/O3ot09R23Ot6x349loW9c5HoZAh?= =?iso-8859-1?Q?2ff+KLDeE4jGvgRgX5AoQr39laUqCAq4BeTzPQ53EFqEBsBxg/4MR4GPy8?= =?iso-8859-1?Q?GspRdFGQDpmcO0RSOzL2u6bxrH6v6/KXS0NKxfTQne6UyqlFTKJNp4d8GF?= =?iso-8859-1?Q?omxQeXNu60++4=3D?= Content-Type: multipart/alternative; boundary="_000_SCZP152MB5822F9CE50C2985FBE71DB02E0592SCZP152MB5822LAMP_" MIME-Version: 1.0 X-OriginatorOrg: ufpr.br X-MS-Exchange-CrossTenant-AuthAs: Internal X-MS-Exchange-CrossTenant-AuthSource: SCZP152MB5822.LAMP152.PROD.OUTLOOK.COM X-MS-Exchange-CrossTenant-Network-Message-Id: f7be7eae-f9b5-4731-77d9-08dc37534e74 X-MS-Exchange-CrossTenant-originalarrivaltime: 27 Feb 2024 05:16:51.7498 (UTC) X-MS-Exchange-CrossTenant-fromentityheader: Hosted X-MS-Exchange-CrossTenant-id: c37b37a3-e9e2-42f9-bc67-4b9b738e1df0 X-MS-Exchange-CrossTenant-mailboxtype: HOSTED X-MS-Exchange-CrossTenant-userprincipalname: s0D+TzWG/Xptsr/WrhEKSykIfvh5SKae6rynG2l4fHO4nrU50+pdhWGwixOHkowJtVuoLZqbD4R7XdoQKhaCpQ== X-MS-Exchange-Transport-CrossTenantHeadersStamped: CPTP152MB4197 X-Spam-Status: No, score=1.6 required=5.0 tests=BAYES_50,DKIM_SIGNED,DKIM_VALID,DKIM_VALID_AU,DKIM_VALID_EF,HTML_MESSAGE,MISSING_HEADERS,RCVD_IN_DNSWL_NONE,RCVD_IN_MSPIKE_H2,SPF_HELO_PASS,SPF_PASS,TXREP,T_SCC_BODY_TEXT_LINE autolearn=no autolearn_force=no version=3.4.6 X-Spam-Level: * X-Spam-Checker-Version: SpamAssassin 3.4.6 (2021-04-09) on server2.sourceware.org List-Id: --_000_SCZP152MB5822F9CE50C2985FBE71DB02E0592SCZP152MB5822LAMP_ Content-Type: text/plain; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable Hello Dear, I am Cesandra Pace, a Research Assistant working with Pharma CURE Laborator= y Ltd. We are Bio-pharmaceutical Company here in the U.K. I'm looking for a reliable businessman/individual in your region to represe= nt this company in sourcing some of our basic raw materials used for the ma= nufacturing of high quality Anti-Viral Vaccines, Cancer treatment medicatio= ns and other lifesaving Pharmaceutical Products. When i receive a response from you, i shall divulge you my intent for your = consideration. Best regards, Cesandra Pace Research & Dev Dept- Pharma CURE Laboratory Ltd UK --_000_SCZP152MB5822F9CE50C2985FBE71DB02E0592SCZP152MB5822LAMP_--